{"id":"NCT01134393","sponsor":"Boehringer Ingelheim","briefTitle":"TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch","officialTitle":"A Prospective, Open-label TElmisartan/AMlodipine Single Pill STudy to Assess the Efficacy in Patients With Essential Hypertension\"...\"","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2011-05","completion":null,"firstPosted":"2010-06-02","resultsPosted":"2012-07-04","lastUpdate":"2014-01-15"},"enrollment":502,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"telmisartan/amlodipine","otherNames":[]}],"arms":[{"label":"telmisartan/amlodipine","type":"EXPERIMENTAL"}],"summary":"The general aim of this trial to determine the efficacy as measured by the percentage of patients reaching blood pressure goal at the end of the treatment period at 12 weeks. In-clinic blood pressures, home blood pressures and safety will be carefully monitored.","primaryOutcome":{"measure":"Percentage of Patients Achieving Blood Pressure (BP) Control After 12 Weeks of Treatment Using In-clinic BP Measurements.","timeFrame":"12 weeks","effectByArm":[{"arm":"T80/A5","deltaMin":67.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":47,"countries":["Germany","Italy","Mexico","Netherlands","Poland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":501},"commonTop":["Oedema peripheral"]}}